Stock Scorer

ICU Medical Inc/de (ICUI)

163.23USD -0.41% (-0.68)

Over 5Y: -30.9%

Style
Area Line Line with markersshows 1Y Steps Candlesshows 6M Hollow candlesshows 6M Barsshows 6M

Candles and bars need the day’s open, high and low, and need room to be drawn in: past about a year of trading a body is thinner than a hairline, so those three offer the longest window that fits instead.

100 150 200 250
2022 2023 2024 2025 2026

Financials Quarterly

Figures
Revenue Gross Profit Operating Income Cost of Revenue Operating Cash Flow Free Cash Flow Net Income

A share count and earnings a share are not here: neither is money, so neither can share this axis. Both have their own panel on All charts.

All charts ›

ICU Medical Inc/de reported revenue of 551.7M USD for the quarter ending 30 June 2026, up 0.5% from 548.9M a year earlier. Every figure, period by period ›

Q3 '21 — Revenue: 336.1M Q3 '21 — Operating Cash Flow: 78.8M Q3 '21 — Free Cash Flow: 62.1M Q3 '21 — Net Income: 31.1M Q4 '21 — Revenue: 340.5M Q4 '21 — Operating Cash Flow: 82.6M Q4 '21 — Free Cash Flow: 60.5M Q4 '21 — Net Income: 19.9M Q1 '22 — Revenue: 543.1M Q1 '22 — Operating Cash Flow: -1.3M Q1 '22 — Free Cash Flow: -24.9M Q1 '22 — Net Income: -38.1M Q2 '22 — Revenue: 561M Q2 '22 — Operating Cash Flow: -61.4M Q2 '22 — Free Cash Flow: -85.8M Q2 '22 — Net Income: -7.5M Q3 '22 — Revenue: 597.9M Q3 '22 — Operating Cash Flow: 2.3M Q3 '22 — Free Cash Flow: -18.4M Q3 '22 — Net Income: -9.8M Q4 '22 — Revenue: 578M Q4 '22 — Operating Cash Flow: -1.7M Q4 '22 — Free Cash Flow: -23.3M Q4 '22 — Net Income: -18.9M Q1 '23 — Revenue: 568.6M Q1 '23 — Operating Cash Flow: 41.2M Q1 '23 — Free Cash Flow: 27M Q1 '23 — Net Income: -9.8M Q2 '23 — Revenue: 549.3M Q2 '23 — Operating Cash Flow: -1.5M Q2 '23 — Free Cash Flow: -19.8M Q2 '23 — Net Income: -9.9M Q3 '23 — Revenue: 553.3M Q3 '23 — Operating Cash Flow: 35.2M Q3 '23 — Free Cash Flow: 13.7M Q3 '23 — Net Income: 7.2M Q4 '23 — Revenue: 587.9M Q4 '23 — Operating Cash Flow: 91.3M Q4 '23 — Free Cash Flow: 61.3M Q4 '23 — Net Income: -17.1M Q1 '24 — Revenue: 566.7M Q1 '24 — Operating Cash Flow: 45.8M Q1 '24 — Free Cash Flow: 29.9M Q1 '24 — Net Income: -39.5M Q2 '24 — Revenue: 596.5M Q2 '24 — Operating Cash Flow: 82M Q2 '24 — Free Cash Flow: 62.5M Q2 '24 — Net Income: -21.4M Q3 '24 — Revenue: 589.1M Q3 '24 — Operating Cash Flow: 36.1M Q3 '24 — Free Cash Flow: 16.2M Q3 '24 — Net Income: -33M Q4 '24 — Revenue: 629.8M Q4 '24 — Operating Cash Flow: 40.2M Q4 '24 — Free Cash Flow: 16.1M Q4 '24 — Net Income: -23.8M Q1 '25 — Revenue: 604.7M Q1 '25 — Operating Cash Flow: 51.3M Q1 '25 — Free Cash Flow: 36.7M Q1 '25 — Net Income: -15.5M Q2 '25 — Revenue: 548.9M Q2 '25 — Operating Cash Flow: 11.2M Q2 '25 — Free Cash Flow: -8.5M Q2 '25 — Net Income: 35.3M Q3 '25 — Revenue: 537M Q3 '25 — Operating Cash Flow: 56.7M Q3 '25 — Free Cash Flow: 27.6M Q3 '25 — Net Income: -3.4M Q4 '25 — Revenue: 540.7M Q4 '25 — Operating Cash Flow: 60.6M Q4 '25 — Free Cash Flow: 36M Q4 '25 — Net Income: -15.7M Q1 '26 — Revenue: 530.2M Q1 '26 — Operating Cash Flow: 38.9M Q1 '26 — Free Cash Flow: 27.6M Q1 '26 — Net Income: 30.1M Q2 '26 — Revenue: 551.7M Q2 '26 — Operating Cash Flow: 80.2M Q2 '26 — Free Cash Flow: 61.6M Q2 '26 — Net Income: 19.1M 0 150M 300M 450M 600M 750M
Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26
Revenue Operating Cash Flow Free Cash Flow Net Income

How it scores

For a valuation multiple, the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

4.0
Accruals -5.2%
OCF / EBIT 3.3×
DSO 31.0 days
SG&A / sales 28.5%
Gross margin 39.1%
OCF margin 10.9%
FCF margin 7.1%
OE margin 4.5%
ROCE 2.1%
ROA 0.76%
ROE 1.4%
ROIC 1.8%

19 of 19 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

5.0
PEG 0.027×
P/B 1.9×
EV/GP 5.9×
P/C 13.7×
Fwd P/E 18.7×
FCF yield 3.7%
EV/OE 51.3×
EV/EBIT 69.7×
P/E 135.7×
EV/Sales 2.3×

10 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

3.9
RPO / sales 0.016×

5 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

5.6
Payout 0.0%
Net debt / Eq 0.44×
F-score 6.0 pts
Debt / Eq 0.57×
Cash / Debt 0.24×
ND/EBITDA -0.19
Quick ratio 1.2×
Debt payback 6.1 yr

12 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

3.0
EPS next Y +701.7%
Sales CAGR 4Y +14.1%
EBIT Y/Y +3.8%
Sales Q/Q +0.51%
EPS CAGR 4Y -71.8%
Sales/sh Y/Y -10.9%

10 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.

Companies of a similar size

The nearest by market value among the companies read here whose shares are quoted in USD. Size alone: nothing here says they are in the same business.

Every listed company from the United States, largest first ›